Mikhail Blagosklonny is currently a professor of Oncology at Cancer School of Roswell Park in Buffalo, New York. He is an author, Mikhail Blagosklonny has written of his two theories in drug production, rapamycin which protect healthy cells from cancer infection. These theory approaches are cell psychotherapy and chemotherapeutic engineering, which help in the fight of the spread of cancer cells in a cancer patient. Mikhail Blagosklonny has a romantic interest in helping prevention of the spread of cancerous cells, he has done research in the clinical survey, cellular and molecular science, in the inclusion of cell cycle study, apoptosis, anticancer therapeutics and mitosis which help to come up with strategies for cancer attack.
Mikhail Blagosklonny went to University of St. Peterburg, school of medical study in First Pavlov State. He pursued both his Master’s Degree (M.D) and doctorate (PhD) in cardiology and experimental medicine. In his career life, Mikhail Blagosklonny was appointed by New York Medical College, located in Valhalla New York, as an Associate Professor in the year 2002. Later he took a position of Senior Scientist at Ordway Research Institute, based in Albany, New York, until 2009 when he joined Roswell Park Cancer Institute as a Professor of Oncology up to date. View Mikhail’s profile on Google Scholar
The skills and experience that Mikhail Blagosklonny gained from his career positions and the knowledge he learned from the above institutions have made him became a great professor. As an author, Mikhail Blagosklonny is an Associate Editor of Therapy and Cancer Biology, a member of Cell Death and Differentiation, Editorial Board and an Editor In Chief of Oncotarget, Ageing of Cells and Cell Cycle Journals.His journals explained the mechanism of ageing, cancer awareness, antiaging drugs, and guards the cancer therapists how to prevent healthy cells from getting damaged.
Having an extreme interest in Oncology has made Mikhail Blagosklonny believe that it’s possible to control cancer and Ageing. In suggestion and development of Rapamycin, he believes cancer can be cured. There are many research articles, reviews and journals that have been published under Professor Mikhail Blagosklonny. He has also been an associate editor of the American Journal of Pathology, among International Journal of Cancer and PLOS ONE. Read more about Mikhail at LinkedIn